Reducing intravenous (IV) isatuximab delivery from 75 minutes to 30 minutes could provide a wealth of benefits to patients ...

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

Hormonal changes at puberty may trigger disease activity, but DMTs reduced the risk, indicating more aggressive treatment may be warranted.

Less frequent Ocrevus infusions are just as effective in controlling MS, but may help limit the risk of side effects, per a ...

The aim of this study is to explore and describe patient-reported experiences of DMD in daily life in patients with MS. For the purpose of decreasing progression of multiple sclerosis (MS ... oral ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, bruises, and sometimes permanent lipoatrophy,” Wyss told more than 800 people ...

Susie Wyss used to inject herself daily with a medication for multiple sclerosis. “The injection hurt. It caused welts, bruises, and sometimes permanent lipoatrophy,” Wyss told more than 800 people ...

infusions, and oral medications targeting different sites in the inflammatory pathway.” RELATED: CNN Anchor John King, 60, Reports in the Field While Managing Multiple Sclerosis — Suffering Quietly ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Therapy for multiple sclerosis progression is a third major research theme. Inhibitors of Bruton's tyrosine kinase (BTK), an intracellular signalling enzyme expressed in B cells and most innate immune ...